Additionally, ginkgetin-mediated inhibition of the miR-122-5p/GALNT10/Smad3 signaling axis significantly attenuated the migratory capacity of breast cancer MDA-MB-231 cells [44]. The gene discussed is GALNT10; the disease is breast carcinoma.